Its aberrant expression in glioblastoma significantly influences tumor cell survival and radioresistance, potentially through interference with the cell cycle via CaMKII, cdc25C, and cdc2 following channel activation (64). The gene discussed is CAMK2G; the disease is glioblastoma.